ATE94410T1 - Verfahren zur herstellung einer festen form mit beibehaltender freisetzung aus einer funktionellen aktiven komposition und die bei dem verfahren erhaltene dosierungsform. - Google Patents

Verfahren zur herstellung einer festen form mit beibehaltender freisetzung aus einer funktionellen aktiven komposition und die bei dem verfahren erhaltene dosierungsform.

Info

Publication number
ATE94410T1
ATE94410T1 AT89900536T AT89900536T ATE94410T1 AT E94410 T1 ATE94410 T1 AT E94410T1 AT 89900536 T AT89900536 T AT 89900536T AT 89900536 T AT89900536 T AT 89900536T AT E94410 T1 ATE94410 T1 AT E94410T1
Authority
AT
Austria
Prior art keywords
sustained release
preparation
active composition
release solid
functional active
Prior art date
Application number
AT89900536T
Other languages
English (en)
Inventor
James William Mcginity
Kuei-Tu Chang
Original Assignee
Univ Texas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas filed Critical Univ Texas
Application granted granted Critical
Publication of ATE94410T1 publication Critical patent/ATE94410T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
AT89900536T 1987-11-24 1988-11-23 Verfahren zur herstellung einer festen form mit beibehaltender freisetzung aus einer funktionellen aktiven komposition und die bei dem verfahren erhaltene dosierungsform. ATE94410T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12470587A 1987-11-24 1987-11-24
PCT/US1988/004208 WO1989004673A1 (en) 1987-11-24 1988-11-23 Method for preparing a solid sustained release form of a functionally active composition and the dosage form so obtained
EP89900536A EP0387300B1 (de) 1987-11-24 1988-11-23 Verfahren zur herstellung einer festen form mit beibehaltender freisetzung aus einer funktionellen aktiven komposition und die bei dem verfahren erhaltene dosierungsform

Publications (1)

Publication Number Publication Date
ATE94410T1 true ATE94410T1 (de) 1993-10-15

Family

ID=22416371

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89900536T ATE94410T1 (de) 1987-11-24 1988-11-23 Verfahren zur herstellung einer festen form mit beibehaltender freisetzung aus einer funktionellen aktiven komposition und die bei dem verfahren erhaltene dosierungsform.

Country Status (9)

Country Link
EP (1) EP0387300B1 (de)
JP (1) JPH02503315A (de)
KR (1) KR890701138A (de)
AT (1) ATE94410T1 (de)
AU (1) AU2793989A (de)
CA (1) CA1334379C (de)
DE (1) DE3884214T2 (de)
MX (1) MX163553B (de)
WO (1) WO1989004673A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE69555B1 (en) * 1989-01-31 1996-10-02 Int Pharma Agentur An erosion-controlled release system for active agents and a process for its preparation
DK469989D0 (da) * 1989-09-22 1989-09-22 Bukh Meditec Farmaceutisk praeparat
DE59006217D1 (de) * 1989-11-30 1994-07-28 Danubia Petrochem Polymere Nicht wirkstoffretardierender Pressling, Verfahren zu dessen Herstellung und Verwendung von Polyhydroxybuttersäure zur Herstellung eines solchen Presslings.
DE4000155A1 (de) * 1990-01-04 1991-07-11 Chemie Linz Deutschland Nicht wirkstoffretardierender pressling, verfahren zu dessen herstellung und verwendung von polyhydroxybuttersaeure zur herstellung eines solchen presslings
AT397345B (de) * 1990-04-04 1994-03-25 Chemiefaser Lenzing Ag Pharmazeutisches präparat mit verzögerter wirkstofffreisetzung auf basis von hemicellulosen
US5429825A (en) * 1992-06-26 1995-07-04 Mcneil-Ppc, Inc. Rotomelt granulation
JP3277342B2 (ja) * 1992-09-02 2002-04-22 武田薬品工業株式会社 徐放性マイクロカプセルの製造法
TW333456B (en) 1992-12-07 1998-06-11 Takeda Pharm Ind Co Ltd A pharmaceutical composition of sustained-release preparation the invention relates to a pharmaceutical composition of sustained-release preparation which comprises a physiologically active peptide.
WO1996019200A1 (fr) * 1994-12-19 1996-06-27 Daiichi Pharmaceutical Co., Ltd. Preparation granulaire a liberation prolongee et procede de production
US5656294A (en) * 1995-06-07 1997-08-12 Cibus Pharmaceutical, Inc. Colonic delivery of drugs
US5811388A (en) * 1995-06-07 1998-09-22 Cibus Pharmaceutical, Inc. Delivery of drugs to the lower GI tract
EP0753539B1 (de) * 1995-07-13 2001-10-10 Mitsubishi Gas Chemical Company, Inc. Polymermischungen aliphatischer Polyester auf Basis von Polylactiden, Verfahren zu deren Herstellung und Verfahren zum Formen diese Mischungen
TW448055B (en) * 1995-09-04 2001-08-01 Takeda Chemical Industries Ltd Method of production of sustained-release preparation
CA2192773C (en) 1995-12-15 2008-09-23 Hiroaki Okada Production of sustained-release preparation for injection
US6419961B1 (en) 1996-08-29 2002-07-16 Takeda Chemical Industries, Ltd. Sustained release microcapsules of a bioactive substance and a biodegradable polymer
EP1049458B1 (de) 1998-01-21 2003-03-26 Takeda Chemical Industries, Ltd. Verfahren zur gerfriertrocknung von präparaten mit verzörgerter wirkstoffabgabe
JP4549529B2 (ja) * 1998-01-30 2010-09-22 サイオス，インコーポレーテッド ペプチドまたはタンパク質の制御放出送達
CN100356907C (zh) * 2001-06-08 2007-12-26 恩德制药公司 利用丙烯酸酯聚合物的控释剂型和其制备方法
CN101115469A (zh) * 2004-12-28 2008-01-30 卫材R&D管理有限公司 速崩片及其制造方法
KR102370559B1 (ko) * 2014-01-23 2022-03-04 마오리 에스.씨. 리미티드 향기나는 신체 조성물
US10328015B2 (en) 2014-01-23 2019-06-25 Amkiri Ltd. Fragrance releasing compositions

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE27107E (en) * 1968-05-01 1971-03-30 Drug composition
JPS5138412A (en) * 1974-09-24 1976-03-31 Nippon Kayaku Kk Kokoseizai no seiho
DE2930321A1 (de) * 1978-09-25 1980-04-10 Jenapharm Veb Verfahren zur herstellung eines neuen pharmazeutischen hilfsstoffes und daraus hergestellte feste arzneiformen
GB2042888B (en) * 1979-03-05 1983-09-28 Teijin Ltd Preparation for administration to the mucosa of the oral or nasal cavity
US4308251A (en) * 1980-01-11 1981-12-29 Boots Pharmaceuticals, Inc. Controlled release formulations of orally-active medicaments
IT1168014B (it) * 1981-08-05 1987-05-20 Erba Farmitalia Forme farmaceutiche a cessione protratta
DE3435325A1 (de) * 1983-04-09 1986-04-17 Nikken Chemicals Co., Ltd., Tokio/Tokyo Langzeitwirkende theophyllin-tablette und verfahren zu deren herstellung
HU190619B (en) * 1983-11-11 1986-09-29 Bezzegh,Denes,Hu Process for producing tablets with controlled dissolution of active ingredients
JPS62223112A (ja) * 1986-03-25 1987-10-01 Rooto Seiyaku Kk 歯周病治療剤
DE3612212A1 (de) * 1986-04-11 1987-10-15 Basf Ag Verfahren zur herstellung von festen pharmazeutischen formen
US4725342A (en) * 1986-11-10 1988-02-16 Yale University Photochemical dimerization and functionalization of alkanes, ethers, primary alcohols and silanes

Also Published As

Publication number Publication date
MX163553B (es) 1992-05-29
EP0387300A1 (de) 1990-09-19
EP0387300B1 (de) 1993-09-15
KR890701138A (ko) 1989-12-19
JPH02503315A (ja) 1990-10-11
DE3884214D1 (de) 1993-10-21
DE3884214T2 (de) 1994-01-13
AU2793989A (en) 1989-06-14
CA1334379C (en) 1995-02-14
WO1989004673A1 (en) 1989-06-01

Similar Documents

Publication Publication Date Title
ATE94410T1 (de) Verfahren zur herstellung einer festen form mit beibehaltender freisetzung aus einer funktionellen aktiven komposition und die bei dem verfahren erhaltene dosierungsform.
DE69326163D1 (de) Verfahren zur herstellung von arzneiformen und kontrollierte freigabe und die soerhaltenen arzneiformen
NZ213245A (en) Controlled-release coated pharmaceutical tablets
UA18251A (uk) Спосіб одержаhhя таблеток з безперервhим виділеhhям лікарського засобу
CA2011637A1 (en) Compositions for the sustained-release of chlorhexidine
DE69023183T2 (de) Rotogranulate und geschmacksabdeckende Überzüge zur Herstellung pharmazeutischer Kautabletten.
IL78826A (en) Precursor composition for the preparation of a biodegradable implant for the sustained release of an active material and such implants prepared therefrom
DE59206345D1 (de) Verfahren zur Herstellung mechanisch stabiler, gut zerfallender Komprimate aus kleinen wirkstoffhaltigen Formkörpern
DE58906926D1 (de) Neue Arzneimittelformulierung sowie Verfahren zu deren Herstellung.
FI914354A (fi) Menetelmä säädellysti lääkeainetta vapauttavan valmisteen valmistamiseksi
DE60036807D1 (de) Verfahren zur herstellung eines pharmazeutischen kaugummis
ATE260645T1 (de) Agitationsunabhängige pharmazeutische multiple- unit-retardzubereitungen und verfahren zu ihrer herstellung
HUT51269A (en) Process for producing benzimidazole derivatives and pharmaceutical compositions comprising same
DE60211769D1 (de) Verfahren zur Herstellung von Arzneistoffgranulatkörnern, die Arzneistoffgranulatkörner sowie diese enthaltende pharmazeutische Zubereitungen
IL115138A (en) Implantable polymer-containing molded articles for the administration of active substances to plants and processes for the preparation thereof
ATE442852T1 (de) Trimetazidine enthaltendes arzneimittel mit verzögerter wirkstoffabgabe und verfahren zur herstellung
CA2194610A1 (en) Sustained-Release Formulation of Animal Growth Hormone and Process for Preparation Thereof
ATE86489T1 (de) Hilfsmittelfreie riboflavingranulate.
ES2004693A6 (es) Un procedimiento para la preparacion de una composicion farmaceutica solida administrable por via oral, que contiene vinburnina como principio activo.
UA31437A (uk) Спосіб одержання лікарського засобу "йохімбін гідрохлорид" у формі таблеток

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee